TNF-α signal transduction in rat neonatal cardiac myocytes:: definition of pathways generating from the TNF-α receptor

被引:72
作者
Condorelli, G
Morisco, C
Latronico, MVG
Claudio, PP
Dent, P
Tsichlis, P
Condorelli, G
Frati, G
Drusco, A
Croce, CM
Napoli, C
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Univ Roma La Sapienza, Fac Med 2, I-00161 Rome, Italy
[3] IRCCS Neuromed, Pozzilli, IS, Italy
[4] Univ Naples, Dept Med, I-80131 Naples, Italy
[5] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Dept Radiat Oncol, Richmond, VA 23298 USA
[6] CNR, Ctr Endocrinol & Endocrinol Sperimentale, I-80131 Naples, Italy
[7] Temple Univ, Sbarro Inst Canc Res, Coll Sci & Technol, Dept Biotechnol, Philadelphia, PA 19122 USA
关键词
cardiomyocyte apoptosis; hypertrophy; AKT; heart failure; tumor necrosis factor alpha;
D O I
10.1096/fj.02-0419com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cardiomyocyte hypertrophy and apoptosis have been implicated in the loss of contractile function during heart failure (HF). Moreover, patients with HF have been shown to exhibit increased levels of tumor necrosis factor alpha (TNF-alpha) in the myocardium. However, the multiple signal transduction pathways generating from the TNF-alpha receptor in cardiomyocytes and leading preferentially to apoptosis or hypertrophy are still unknown. Here we demonstrate in neonatal rat cardiomyocytes that 1) TNF-alpha induces phosphorylation of AKT, activation of NF-kappaB, and the phosphorylation of JUN kinase; 2) blocking AKT activity prevents NF-kappaB activation, suggesting a role for AKT in regulating NF-kappaB function; 3) AKT and JUN are both critical for the hypertrophic effects of TNF-alpha, since dominant-negative mutants of these genes are capable of inhibiting TNF-alpha-induced ANF-promoter up-regulation and increase in cardiomyocyte cell size, and 4) blocking NF-kappaB, AKT, or JUN alone or in combination does not sensitize cardiomyocytes to the proapoptotic effects of TNF-alpha, in contrast to other cell types, suggesting a cardiac-specific pathway regulating the anti-apoptotic events induced by TNF-alpha. Altogether, the data presented evidence the role of AKT and JUN in TNF-alpha-induced cardiomyocyte hypertrophy and apoptosis.
引用
收藏
页码:1732 / 1737
页数:6
相关论文
共 22 条
[1]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[2]   The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes [J].
Auer, KL ;
Contessa, J ;
Brenz-Verca, S ;
Pirola, L ;
Rusconi, S ;
Cooper, G ;
Abo, A ;
Wymann, MP ;
Davis, RJ ;
Birrer, M ;
Dent, P .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (03) :561-573
[3]   Akt activation by growth factors is a multiple-step process: the role of the PH domain [J].
Bellacosa, A ;
Chan, TO ;
Ahmed, NN ;
Datta, K ;
Malstrom, S ;
Stokoe, D ;
McCormick, F ;
Feng, JN ;
Tsichlis, P .
ONCOGENE, 1998, 17 (03) :313-325
[4]   The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release [J].
Bradham, CA ;
Qian, T ;
Streetz, K ;
Trautwein, C ;
Brenner, DA ;
Lemasters, JJ .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6353-6364
[5]   Stress pathways and heart failure [J].
Chien, KR .
CELL, 1999, 98 (05) :555-558
[6]  
Claudio PP, 1999, CIRC RES, V85, P1032
[7]   p38 MAPK and NF-κB collaborate to induce interleukin-6 gene expression and release -: Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system [J].
Craig, R ;
Larkin, A ;
Mingo, AM ;
Thuerauf, DJ ;
Andrews, C ;
McDonough, PM ;
Glembotski, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :23814-23824
[8]   Bcl-2 activates the transcription factor NFκB through the degradation of the cytoplasmic inhibitor IκBα [J].
de Moissac, D ;
Mustapha, S ;
Greenberg, AH ;
Kirshenbaum, LA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) :23946-23951
[9]   Safety and efficacy of a soluble P75 tumor necrosis factor receptor (enbrel, etanercept) in patients with advanced heart failure [J].
Deswal, A ;
Bozkurt, B ;
Seta, Y ;
Parilti-Eiswirth, S ;
Hayes, FA ;
Blosch, C ;
Mann, DL .
CIRCULATION, 1999, 99 (25) :3224-3226
[10]   Losing heart: the role of apoptosis in heart disease - a novel therapeutic target? [J].
Gill, C ;
Mestril, R ;
Samali, A .
FASEB JOURNAL, 2002, 16 (02) :135-146